Replies to post #4001 on Positron Corporation (POSC)

[pennyrobin]

Listen to COV 30:00-34:20. Historically COV has not been involved greatly in cardiology. COV guy says they're developing their vascular line, "not including the heart". This is plausible and would seem to exclude POSC--unless he's lying! If the company was planning to enter cardiology, they wouldn't want competitors to know at this stage. The discussion of the radiopharm sale (32:00-34:20) is oozing with the same reticence, evasiveness and fumbling nervousness that we're getting from Rooney. It's very clear from his comments that the radiopharm sale--probably in the "June quarter"--preceeds new acquisitions. It's COV, and we'll know in the next "month or so" (Rooney's exact words.)